Artículos por temáticas

Parkinsonism in PGK1 deficiency implicates the glycolytic pathway in nigrostriatal dysfunction.

Morales-Briceño H, Ha AD, London K, Farlow D, Chang FCF, Fung VSC.

Parkinsonism Relat Disord. 2019 Jul;64:319-323. doi: 10.1016/j.parkreldis.2019.04.004. Epub 2019 Apr 5.

Corneal Evaluation in Patients With Parkinsonism on Long-Term Amantadine Therapy.

Daggumilli S, Vanathi M, Ganger A, Goyal V, Tandon R.

Cornea. 2019 Sep;38(9):1131-1136. doi: 10.1097/ICO.0000000000001951.

Integration and Extension of Specialty Mental Healthcare Services to Community Practice in Parkinson Disease.

Pontone GM, Dissanayaka N, Dobkin RD, Mari L, Marsh L, Vernaleo BA, Weintraub D, Mari Z.

Am J Geriatr Psychiatry. 2019 Jul;27(7):712-719. doi: 10.1016/j.jagp.2019.03.005. Epub 2019 Mar 13.

Resveratrol synergizes with low doses of L-DOPA to improve MPTP-induced Parkinson disease in mice.

Liu Q, Zhu D, Jiang P, Tang X, Lang Q, Yu Q, Zhang S, Che Y, Feng X.

Behav Brain Res. 2019 Jul 23;367:10-18. doi: 10.1016/j.bbr.2019.03.043. Epub 2019 Mar 25.

Effects of non-invasive brain stimulation on freezing of gait in parkinsonism: A systematic review with meta-analysis.

Kim YW, Shin IS, Moon HI, Lee SC, Yoon SY.

Parkinsonism Relat Disord. 2019 Jul;64:82-89. doi: 10.1016/j.parkreldis.2019.02.029. Epub 2019 Feb 27.

Neuroprotective effects of an engineered commensal bacterium in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine Parkinson disease mouse model via producing glucagon-like peptide-1.

Fang X, Tian P, Zhao X, Jiang C, Chen T.

J Neurochem. 2019 Aug;150(4):441-452. doi: 10.1111/jnc.14694. Epub 2019 Apr 1.

Systematic Literature Review of Quetiapine for the Treatment of Psychosis in Patients With Parkinsonism.

Chen JJ, Hua H, Massihi L, Portillo I, Alipour A, Ondo W, Dashtipour K.

J Neuropsychiatry Clin Neurosci. 2019 Summer;31(3):188-195. doi: 10.1176/appi.neuropsych.18080180. Epub 2019 Mar 8.

Rescuing Suboptimal Outcomes of Subthalamic Deep Brain Stimulation in Parkinson Disease by Surgical Lead Revision.

Nickl RC, Reich MM, Pozzi NG, Fricke P, Lange F, Roothans J, Volkmann J, Matthies C.

Neurosurgery. 2019 Aug 1;85(2):E314-E321. doi: 10.1093/neuros/nyz018.

Flexed Posture in Parkinson Disease: Associations With Nonmotor Impairments and Activity Limitations.

Forsyth AL, Joshi RY, Canning CG, Allen NE, Paul SS.

Phys Ther. 2019 Jul 1;99(7):893-903. doi: 10.1093/ptj/pzz033.

Parkinsonism Relating to Intoxication with Glyphosate.

Eriguchi M, Iida K, Ikeda S, Osoegawa M, Nishioka K, Hattori N, Nagayama H, Hara H.

Intern Med. 2019 Jul 1;58(13):1935-1938. doi: 10.2169/internalmedicine.2028-18. Epub 2019 Feb 25.

Assessment of APOE in atypical parkinsonism syndromes.

Sabir MS, Blauwendraat C, Ahmed S, Serrano GE, Beach TG, Perkins M, Rice AC, Masliah E, Morris CM, Pihlstrom L, Pantelyat A, Resnick SM, Cookson MR, Hernandez DG, Albert M, Dawson TM, Rosenthal LS, Ho

Neurobiol Dis. 2019 Jul;127:142-146. doi: 10.1016/j.nbd.2019.02.016. Epub 2019 Feb 21.

Parkinsonism Caused by Viral Encephalitis Affecting the Bilateral Substantia Nigra.

Liu X, Deng F, Chen L.

Clin Neuroradiol. 2019 Sep;29(3):571-573. doi: 10.1007/s00062-019-00769-1. Epub 2019 Feb 22. No abstract available.

Fact-finding survey on diagnostic procedures and therapeutic interventions for parkinsonism accompanying dementia with Lewy bodies.

Manabe Y, Odawara T, Konishi O.

Psychogeriatrics. 2019 Jul;19(4):345-354. doi: 10.1111/psyg.12408. Epub 2019 Feb 19.

Glutamate and GABA neurotransmission are increased in paraventricular nucleus of hypothalamus in rats induced to 6-OHDA parkinsonism: Involvement of nNOS.

Turossi Amorim ED, de Jager L, Martins AB, Rodrigues AT, Cruz Lucchetti BF, Ariza D, Pinge-Filho P, Crestani CC, Uchoa ET, Martins-Pinge MC.

Acta Physiol (Oxf). 2019 Jul;226(3):e13264. doi: 10.1111/apha.13264. Epub 2019 Feb 27.

Chemicals, somatic mutations and neurodegeneration: evidence from Western Pacific amyotrophic lateral sclerosis-parkinsonism-dementia complex (ALS-PDC): Commentary on: Leija-Salazar M, Piette C, Proukakis C. Review: Somatic mutations in neurodegeneration. Neuropathol Appl Neurobiol 2018; 44: 267-85.

Spencer PS, Kisby G.

Neuropathol Appl Neurobiol. 2019 Aug;45(5):525-527. doi: 10.1111/nan.12533. Epub 2019 Feb 11. No abstract available.